![Quiver Logo](/static/img/logo-icon.png)
![CADL logo](https://quiver-logos.s3.us-east-2.amazonaws.com/cadl.png)
Candel Therapeutics, Inc. Common Stock
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CADL Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of CADL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CADL's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to CADL
Recent picks made for CADL stock on CNBC
ETFs with the largest estimated holdings in CADL
Flights by private jets registered to CADL
![Quiver Logo](/static/img/logo-icon.png)